Beranda › Neoplasma Mieloproliferatif › New York

Uji klinis Neoplasma Mieloproliferatif di New York

15 studi untuk Neoplasma Mieloproliferatif mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NYP/Weill Cornell Medical Center, New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06661915

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Northwell Health/Center for Advanced Medicine, Lake Success
dan 9 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Memorial Sloan Kettering Cancer Center, New York
Icahn School of Medicine at Mount Sinai, New York
Montefiore, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
dan 9 lainnya

Menerima pesertaFase 2

Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05554406

Cord Blood Transplant in Adults With Blood Cancers

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 2

Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05884333

Project: Every Child for Younger Patients With Cancer

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
dan 12 lainnya

Menerima pesertaStudi observasional

Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Icahn School of Medicine At Mount Sinai, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Memorial Sloan Kettering Cancer Center, New York
Mount Sinai School of Medicine, New York
Weill Cornell Medicine, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07441694

Asciminib Roll-over Study

Memorial Sloan Kettering, New York

Menerima pesertaFase 4

Usia 7 hingga 100 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04877522

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Icahn School of Medicine At Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT06034002

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Memorial Sloan Kettering, New York

Menerima pesertaFase 2

Usia 18 hingga 66 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06859424

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 2

Hingga usia 21 · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT04644016

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07362225

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
dan 2 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Columbia University, New York
Montefiore Einstein Cancer Center, The Bronx

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2025 · NCT05423691

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.